はじめての方へ
ショーケース
価格
ログイン
無料体験
米国企業
Innate Pharma SA
Innate Pharma SA
IPHA
時価総額
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
EUR
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Revenue from contracts with customers
69
56
12
50
Government financing for research expenditures
-
14
13
8
Other income
-
-
-
0
Total revenue and other income
86
70
25
58
Research and development expenses
79
59
47
52
General and administrative expenses
26
31
26
22
Impairment of intangible assets
-
44
-
41
Total operating expenses
105
133
73
115
Net income (loss) from distribution agreements
-
1
-
-
Operating income (loss)
-27
-62
-48
-57
Finance income
11
5
6
5
Financial expenses
5
7
4
5
Net financial income (loss)
6
-
2
-1
Net income (loss) before tax
-21
-64
-45
-58
Net income (loss) from continuing operations
-
-
-45
-58
Profit (loss) from discontinued operations
-
-
-7
-0
Net income (loss)
-21
-64
-53
-58
Basic earnings (loss) per share
-0.31
-0.81
-0.66
-0.73
Diluted earnings (loss) per share
-0.31
-0.81
-0.66
-0.73
Basic earnings (loss) per share from continuing operations
-
-
-0.57
-0.73
Diluted earnings (loss) per share from continuing operations
-
-
-0.57
-0.73
Basic earnings (loss) per share from discontinued operations
-
-
-0.09
-
Diluted earnings (loss) per share from discontinued operations
-
-
-0.09
-